Wave Life Sciences Ltd.
WVENASDAQHealthcare● Active
$5.70
$-0.03(-0.52%)
Market Cap$1.1B
P/E Ratio—
52W High$21.73
52W Low$5.02
Wave Life Sciences Ltd. (WVE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · WVE · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $42.73M | $108.30M | $113.31M | $3.65M | $40.96M |
| Cost of Revenue | $8.85M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $33.88M | $108.30M | $113.31M | $3.65M | $40.96M |
| Gross Margin %(computed) | 79.28% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $182.78M | $159.68M | $130.01M | $115.86M | $121.88M |
| G&A Expenses | $75.33M | $59.02M | $51.29M | $50.51M | $46.10M |
| Total Operating Expenses | $249.26M | $218.71M | $181.30M | $166.37M | $167.98M |
| Operating Income | ($215.38M) | ($110.40M) | ($68.00M) | ($162.72M) | ($127.02M) |
| Operating Margin %(computed) | -504.09% | -101.94% | -60.01% | — | -310.07% |
| Interest Income | $10.48M | $0.00M | $0.00M | $0.00M | $0.03M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($204.38M) | ($97.01M) | ($58.19M) | ($161.14M) | ($122.45M) |
| Income Tax Expense | $0.00M | $0.00M | ($0.68M) | $0.68M | ($0.20M) |
| Net Income | ($204.38M) | ($97.01M) | ($57.51M) | ($161.82M) | ($122.25M) |
| Net Margin %(computed) | -478.33% | -89.57% | -50.76% | — | -298.42% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
| Wtd Avg Shares | 168.65M | 138.28M | 106.10M | 78.86M | 51.83M |
| EBITDA | ($195.53M) | ($101.74M) | ($58.79M) | ($152.61M) | ($117.18M) |
| EBITDA Margin %(computed) | -457.62% | -93.94% | -51.89% | — | -286.06% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Wave Life Sciences Ltd. data
About Wave Life Sciences Ltd. (WVE) Income Statement
Wave Life Sciences Ltd. (WVE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, WVE reported revenue of $0.04B, gross profit of $0.03B (gross margin 79.28%), and net income of ($0.20B) — a net profit margin of -478.33%.
Frequently asked questions
WVE · 4 questionsWave Life Sciences Ltd. (WVE) reported revenue of $0.04B for 2025, down 60.5% year-over-year.
WVE revenueWVE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08